Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
This Week in The Journal

This Week in The Journal

Teresa Esch [Ph.D.]
Journal of Neuroscience 15 November 2017, 37 (46) i
Teresa Esch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Teresa Esch
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Estrus-Cycle-Dependent Role of mGluR1 in Opioid Analgesia

Nai-Jiang Liu, Vijaya Murugaiyan, Emiliya M. Storman, Stephen A. Schnell, Arjun Kumar, et al.

(see pages 11181–11191)

Chronic pain conditions are more common in women than in men, and in laboratory studies, women have lower pain thresholds than men. These differences are paralleled by sex differences in both neural activation patterns induced by nociceptive stimuli and the levels or activity of proteins involved in pain processing, including μ-opioid receptors (MORs). Rodent studies have revealed numerous additional sex differences in the cellular mechanisms underlying pain processing.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

During proestrus, activation of a mGluR1–mGluR2/3 complex disinhibits dynorphin (Dyn) release, allowing activation of MORs by endomorphin (EM2) to produce antinociception. During diestrus, estrogen (E2), produced by aromatase (Aro) binds to mERα and prevents signaling through the mGluR1–mGluR2/3 complex. See Liu et al. for details.

Differences in pain processing exist not only between the sexes, but also over the course of the reproductive cycle in females. For example, endomorphin 2, an endogenous MOR ligand, increases pain thresholds similarly in male and proestrus female rats, but this antinociceptive effect requires activation of κ-opioid receptors (KORs) only in females. Moreover, endomorphin-induced antinociception is minimal in diestrus females. This change stems not from reduction in circulating estrogens, as one might predict, but from activation of membrane estrogen receptor α (mERα) on spinal neurons by locally synthesized estrogen. Activated mERα then activates type 1 metabotropic glutamate receptors (mGluR1), which form a complex with mERα in MOR-expressing spinal neurons (Liu et al. 2017 Pain 158:1903).

Blocking either mERα or mGluR1 reinstates endomorphin-mediated antinociception in diestrus female rats. Liu et al. asked whether suppression of this signaling pathway also underlies the emergence of endomorphin antinociception during proestrus. Surprisingly, blocking mGluR1 eliminated antinociception during proestrus, indicating that activation of mGluR1 either promoted or suppressed antinociception, depending on the estrus phase. But blocking glutamate release eliminated antinociception during proestrus, without unmasking antinociception during diestrus. In addition, mGluR1 formed a complex with mGluR2/3 selectively during proestrus, and blocking mGluR2/3 eliminated endomorphin antinociception during this phase. Additional experiments suggested that mGluR1/mGluR2/3 signaling during proestrus led to greater release of the KOR ligand dynorphin, and that inhibition of this release blocks endomorphin-induced antinociception during diestrus.

Together, the results suggest that during proestrus, activation of a mGluR1–mGluR2/3 complex by glutamate removes endomorphin-induced inhibition of dynorphin release, allowing activation of KORs, which is required for endomorphin-mediated antinociception. During diestrus, activated mERα associates with mGluR1, preventing the disinhibition of dynorphin release and thus blocking antinociception. If similar mechanisms exist in humans, they might affect pain processing throughout the menstrual cycle.

Comparing fMRI, LFP, and Spiking after Spinal Lesion

Ruiqi Wu, Pai-Feng Yang, and Li Min Chen

(see pages 11192–11203)

While we lie quietly with eyes closed, our brains are highly active. Functional magnetic resonance imaging (fMRI) performed under such conditions reveals spontaneous waves of activity that are correlated across brain areas. This correlated activity is said to reflect functional connectivity, and it is used extensively to investigate normal and pathological brain function. Functional connectivity doesn't necessarily indicate anatomical connectivity, however: activity in two areas might be correlated because each receives similar inputs, for example. Furthermore, the blood oxygen level-dependent (BOLD) signal used in fMRI measures deoxyhemoglobin levels, an indirect measure of neural activity that depends on how activity affects cerebral blood flow. Although cortical BOLD signals are strongly correlated with local field potentials (LFPs) in healthy animals performing tasks, questions remain about the neural correlates of resting-state BOLD signals, particularly in pathological conditions in which neurovascular coupling might be disrupted. Moreover, how changes in resting-state activity relate to altered brain function is not entirely clear.

Simultaneously recording BOLD signals, LFPs, and spiking in monkeys in healthy and pathological conditions can help address these questions. Wu et al. obtained such recordings from primary (area 3b) and secondary (S2) somatosensory cortex before and after severing dorsal columns, which convey afferent information to these areas via the thalamus. They first examined responses to tactile stimulation, and found that dorsal column lesion reduced responses in 3b and S2 measured by fMRI, LFP, and spiking activity. Activity in these areas during rest was also reduced after lesion, as was resting-state functional connectivity between the areas, as measured by all three signals. Reductions in stimulus responses were much greater than reductions in resting-state correlations, however. Moreover, the magnitude of the reductions—as well as the relationship between reductions in evoked versus resting responses—differed depending on which measure was used.

The fact that lesions reduced stimulus responses more than resting-state correlations in 3b and S2 suggests that these correlations arise only partially from common sensory input. The results also show that resting-state fMRI can detect changes in functional connectivity induced by elimination of afferent input to cortical regions. Nonetheless, the study indicates that changes in the magnitude of BOLD signals might not provide an accurate measure of changes in neural activity.

Footnotes

  • This Week in The Journal was written by Teresa Esch, Ph.D.

Back to top

In this issue

The Journal of Neuroscience: 37 (46)
Journal of Neuroscience
Vol. 37, Issue 46
15 Nov 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Advertising (PDF)
  • Ed Board (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
This Week in The Journal
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
This Week in The Journal
Journal of Neuroscience 15 November 2017, 37 (46) i

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
This Week in The Journal
Journal of Neuroscience 15 November 2017, 37 (46) i
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Estrus-Cycle-Dependent Role of mGluR1 in Opioid Analgesia
    • Comparing fMRI, LFP, and Spiking after Spinal Lesion
    • Footnotes
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

  • This Week in The Journal
  • This Week in The Journal
  • This Week in The Journal
Show more This Week in The Journal
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.